Statistics

Total Visits

Views
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers42

Select a period of time:

Number of views in the range

Views
Adverse events during the titration phase of interferon-beta in remitting-relapsing multiple sclerosis are not predicted by body mass index nor by pharmacodynamic biomarkers20

Views

Views
October 20243
November 20242
December 20241
January 20252
February 20256
March 20253
April 20253
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States15
Singapore3
Spain1
United Kingdom1
 

Top cities views

Views
Ashburn1
Council Bluffs1